Evernest Financial Advisors, LLC Nexgel, Inc. Transaction History
Evernest Financial Advisors, LLC
- $255 Million
- Q1 2025
A detailed history of Evernest Financial Advisors, LLC transactions in Nexgel, Inc. stock. As of the latest transaction made, Evernest Financial Advisors, LLC holds 224,666 shares of NXGL stock, worth $588,624. This represents 0.26% of its overall portfolio holdings.
Number of Shares
224,666Holding current value
$588,624% of portfolio
0.26%Shares
1 transactions
Others Institutions Holding NXGL
# of Institutions
18Shares Held
742KCall Options Held
0Put Options Held
0-
Jim Simons Renaissance Technologies LLC | New York, Ny158KShares$414,8270.0% of portfolio
-
Morgan Stanley New York, NY87.8KShares$230,0460.0% of portfolio
-
Geode Capital Management, LLC Boston, MA60.1KShares$157,5720.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA50.1KShares$131,2670.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA38.5KShares$100,7620.03% of portfolio
About NEXGEL, INC.
- Ticker NXGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 5,572,230
- Market Cap $14.6M
- Description
- NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was...